| Literature DB >> 20683645 |
Sean Ekins1, Rishi R Gupta, Eric Gifford, Barry A Bunin, Chris L Waller.
Abstract
Cheminformatics is at a turning point, the pharmaceutical industry benefits from using the various methods developed over the last twenty years, but in our opinion we need to see greater development of novel approaches that non-experts can use. This will be achieved by more collaborations between software companies, academics and the evolving pharmaceutical industry. We suggest that cheminformatics should also be looking to other industries that use high performance computing technologies for inspiration. We describe the needs and opportunities which may benefit from the development of open cheminformatics technologies, mobile computing, the movement of software to the cloud and precompetitive initiatives.Mesh:
Year: 2010 PMID: 20683645 DOI: 10.1007/s11095-010-0229-0
Source DB: PubMed Journal: Pharm Res ISSN: 0724-8741 Impact factor: 4.200